{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:45:34Z","timestamp":1792575934416,"version":"4.5.0"},"reference-count":46,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,10,1]]},"DOI":"10.3724\/abbs.2026172","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:27:46Z","timestamp":1789709266000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Raman spectroscopy reveals a novel mechanism by which cyclin Y promotes breast cancer progression by regulating lipid metabolism"],"prefix":"10.3724","author":[{"given":"Lingxian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaogan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheguo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengna","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10555-018-9770-9","volume":"37","author":"Auner GW","year":"2018","unstructured":"Auner GW, Koya SK, Huang C, Broadbent B, Trexler M, Auner Z, Elias A. Applications of raman spectroscopy in cancer diagnosis. Cancer Metastasis Rev, 2018, 37: 691-717.","journal-title":"Cancer Metastasis Rev"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.31557\/APJCP.2024.25.11.3977","volume":"25","author":"Jain GK","year":"2024","unstructured":"Jain GK, Verma R, Chougule A, Singh B. Scientific advances in cancer detection using raman spectroscopy. Asian Pac J Cancer Prev, 2024, 25: 3977-3986.","journal-title":"Asian Pac J Cancer Prev"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2024, 74: 229-263.","journal-title":"CA Cancer J Clin"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"Siegel RL","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin, 2024, 74: 12-49.","journal-title":"CA Cancer J Clin"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10555-017-9684-y","volume":"36","author":"Haynes B","year":"2017","unstructured":"Haynes B, Sarma A, Nangia-Makker P, Shekhar MP. Breast cancer complexity: implications of intratumoral heterogeneity in clinical management. Cancer Metastasis Rev, 2017, 36: 547-555.","journal-title":"Cancer Metastasis Rev"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00432-022-04135-6","volume":"149","author":"Zabihi M","year":"2023","unstructured":"Zabihi M, Lotfi R, Yousefi AM, Bashash D. Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities. J Cancer Res Clin Oncol, 2023, 149: 1585-1606.","journal-title":"J Cancer Res Clin Oncol"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1080\/15384101.2022.2162668","volume":"22","author":"Opacka A","year":"2023","unstructured":"Opacka A, \u017bury\u0144 A, Krajewski A, Miko\u0142ajczyk K. The role of cyclin Y in normal and pathological cells. Cell Cycle, 2023, 22: 859-869.","journal-title":"Cell Cycle"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3816\/CLC.2011.n.006","volume":"12","author":"Yue W","year":"2011","unstructured":"Yue W, Zhao X, Zhang L, Xu S, Liu Z, Ma L, Jia W. Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis. Clin Lung Cancer, 2011, 12: 43-50.","journal-title":"Clin Lung Cancer"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.12659\/MSM.906075","volume":"24","author":"Shi K","year":"2018","unstructured":"Shi K, Ru Q, Zhang C, Huang J. Cyclin Y modulates the proliferation, invasion, and metastasis of hepatocellular carcinoma cells. Med Sci Monit, 2018, 24: 1642-1653.","journal-title":"Med Sci Monit"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.febslet.2009.06.010","volume":"583","author":"Jiang M","year":"2009","unstructured":"Jiang M, Gao Y, Yang T, Zhu X, Chen J. Cyclin Y, a novel membrane-associated cyclin, interacts with PFTK1. FEBS Lett, 2009, 583: 2171-2178.","journal-title":"FEBS Lett"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"26427","DOI":"10.1074\/jbc.M116.744607","volume":"291","author":"Wang X","year":"2016","unstructured":"Wang X, Jia Y, Fei C, Song X, Li L. Activation\/proliferation-associated protein 2 (Caprin-2) positively regulates CDK14\/Cyclin Y-mediated lipoprotein receptor-related protein 5 and 6 (LRP5\/6) constitutive phosphorylation. J Biol Chem, 2016, 291: 26427-26434.","journal-title":"J Biol Chem"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1128\/MCB.06261-11","volume":"32","author":"Mikolcevic P","year":"2012","unstructured":"Mikolcevic P, Sigl R, Rauch V, Hess MW, Pfaller K, Barisic M, Pelliniemi LJ. Cyclin-dependent kinase 16\/PCTAIRE kinase 1 is activated by cyclin Y and is essential for spermatogenesis. Mol Cell Biol, 2012, 32: 868-879.","journal-title":"Mol Cell Biol"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s41467-020-14812-0","volume":"11","author":"Dohmen M","year":"2020","unstructured":"Dohmen M, Krieg S, Agalaridis G, Zhu X, Shehata SN, Pfeiffenberger E, Amelang J. AMPK-dependent activation of the cyclin Y\/CDK16 complex controls autophagy. Nat Commun, 2020, 11:","journal-title":"Nat Commun"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1042\/BCJ20160941","volume":"474","author":"Dixon-Clarke SE","year":"2017","unstructured":"Dixon-Clarke SE, Shehata SN, Krojer T, Sharpe TD, von Delft F, Sakamoto K, Bullock AN. Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16. Biochem J, 2017, 474: 699-713.","journal-title":"Biochem J"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"12624","DOI":"10.1038\/srep12624","volume":"5","author":"Cho E","year":"2015","unstructured":"Cho E, Kim DH, Hur YN, Whitcomb DJ, Regan P, Hong JH, Kim H. Cyclin Y inhibits plasticity-induced AMPA receptor exocytosis and LTP. Sci Rep, 2015, 5:","journal-title":"Sci Rep"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41380-022-01877-0","volume":"28","author":"Seo J","year":"2023","unstructured":"Seo J, Hwang H, Sohn H, Cho E, Jung S, Kim S, Um SM. Cyclin Y regulates spatial learning and memory flexibility through distinct control of the actin pathway. Mol Psychiatry, 2023, 28: 1351-1364.","journal-title":"Mol Psychiatry"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11427-010-0090-8","volume":"53","author":"Yue WT","year":"2010","unstructured":"Yue WT, Zhao XT, Zhang LN, Liu ZD, Ma L, Jia WY, Qian Z. Overexpression of cyclin Y in non-small cell lung cancer is associated with cancer cell proliferation. Sci China Life Sci, 2010, 53: 511-516.","journal-title":"Sci China Life Sci"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"10161","DOI":"10.1007\/s13277-016-4818-3","volume":"37","author":"Liu H","year":"2016","unstructured":"Liu H, Shi H, Fan Q, Sun X. Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via wnt signaling pathway. Tumor Biol, 2016, 37: 10161-10175.","journal-title":"Tumor Biol"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"21701","DOI":"10.1038\/s41598-024-72174-9","volume":"14","author":"Murakami Y","year":"2024","unstructured":"Murakami Y, Katsuchi D, Matsumoto T, Kanazawa K, Shibata T, Kawahara A, Akiba J. Y-box binding protein 1\/cyclin A1 axis specifically promotes cell cycle progression at G2\/M phase in ovarian cancer. Sci Rep, 2024, 14:","journal-title":"Sci Rep"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.2147\/CMAR.S241620","volume":"12","author":"Zhao X","year":"2020","unstructured":"Zhao X, Jiang M, Wang Z, Chen X, Wang H, Yue W, Cai C. CCNY accelerates cycline E expression to regulate the proliferation of laryngeal carcinoma cells via MEK\/ERK signaling pathway. Cancer Manag Res, 2020, 12: 4889-4898.","journal-title":"Cancer Manag Res"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.3892\/or.2016.5126","volume":"36","author":"Yan F","year":"2016","unstructured":"Yan F, Wang X, Zhu M, Hu X. RNAi-mediated downregulation of cyclin Y to attenuate human breast cancer cell growth. Oncol Rep, 2016, 36: 2793-2799.","journal-title":"Oncol Rep"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"e1006055","DOI":"10.1371\/journal.pgen.1006055","volume":"12","author":"Zeng L","year":"2016","unstructured":"Zeng L, Cai C, Li S, Wang W, Li Y, Chen J, Zhu X. Essential roles of cyclin Y-like 1 and cyclin y in dividing wnt-responsive mammary stem\/progenitor Cells. PLoS Genet, 2016, 12:","journal-title":"PLoS Genet"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13046-022-02362-w","volume":"41","author":"Li X","year":"2022","unstructured":"Li X, Li J, Xu L, Wei W, Cheng A, Zhang L, Zhang M. CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1. J Exp Clin Cancer Res, 2022, 41:","journal-title":"J Exp Clin Cancer Res"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"111331","DOI":"10.1016\/j.celrep.2022.111331","volume":"40","author":"Zhang M","year":"2022","unstructured":"Zhang M, Zhang L, Geng A, Li X, Zhou Y, Xu L, Zeng YA. CDK14 inhibition reduces mammary stem cell activity and suppresses triple negative breast cancer progression. Cell Rep, 2022, 40:","journal-title":"Cell Rep"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.stem.2007.10.002","volume":"2","author":"Welm BE","year":"2008","unstructured":"Welm BE, Dijkgraaf GJP, Bledau AS, Welm AL, Werb Z. Lentiviral transduction of mammary stem cells for analysis of gene function during development and cancer. Cell Stem Cell, 2008, 2: 90-102.","journal-title":"Cell Stem Cell"},{"key":"CITATION26","doi-asserted-by":"publisher","DOI":"10.3791\/53409","author":"Berens EB","year":"2015","unstructured":"Berens EB, Holy JM, Riegel AT, Wellstein A. A cancer cell spheroid assay to assess invasion in a 3D setting.  J Vis Exp, 2015,","journal-title":"J Vis Exp"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/nm.2454","volume":"17","author":"DeRose YS","year":"2011","unstructured":"DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, Ebbert MTW, Factor R. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med, 2011, 17: 1514-1520.","journal-title":"Nat Med"},{"key":"CITATION28","doi-asserted-by":"publisher","DOI":"10.1002\/0471141755.ph1423s60","volume":"60","author":"DeRose YS","year":"2013","unstructured":"DeRose YS, Gligorich KM, Wang G, Georgelas A, Bowman P, Courdy SJ, Welm AL. Patient-derived models of human breast cancer: protocols for in vivo and in vivo applications in tumor biology and translational medicine. CP Pharmacol, 2013, 60:","journal-title":"CP Pharmacol"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"qzaf072","DOI":"10.1093\/gpbjnl\/qzaf072","volume":"23","author":"Zhang S","year":"2025","unstructured":"Zhang S, Chen X, Jin E, Wang A, Chen T, Zhang X, Zhu J. The GSA family in 2025: a broadened sharing platform for multi-omics and multimodal data. Genomics Proteomics BioInf, 2025, 23:","journal-title":"Genomics Proteomics BioInf"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"D30","DOI":"10.1093\/nar\/gkae978","volume":"53","author":"Bao Y","year":"2025","unstructured":"Bao Y, Bai X, Bu C, Chen H, Chen H, Chen K, Chen M. Database resources of the national genomics data center, china national center for bioinformation in 2025. Nucleic Acids Res, 2025, 53: D30-D44.","journal-title":"Nucleic Acids Res"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"Subramanian A","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA, 2005, 102: 15545-15550.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"Yu G","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS-J Integr Biol, 2012, 16: 284-287.","journal-title":"OMICS-J Integr Biol"},{"key":"CITATION33","doi-asserted-by":"crossref","unstructured":"Gy\u0151rffy B. Pharmacologically actionable transcriptomic signatures across immune infiltration subtypes in the KM-plotter breast cancer cohort.  Advances in Translational Research  2026, 1: 193\u2013204.","DOI":"10.1556\/1661.2026.00008"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gkab418","volume":"49","author":"Li C","year":"2021","unstructured":"Li C, Tang Z, Zhang W, Ye Z, Liu F. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res, 2021, 49: W242-W246.","journal-title":"Nucleic Acids Res"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3390\/molecules23081941","volume":"23","author":"Petan T","year":"2018","unstructured":"Petan T, Jarc E, Jusovi\u0107 M. Lipid droplets in cancer: guardians of fat in a stressful world. Molecules, 2018, 23:","journal-title":"Molecules"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/1873-3468.14820","volume":"598","author":"Safi R","year":"2024","unstructured":"Safi R, Men\u00e9ndez P, Pol A. Lipid droplets provide metabolic flexibility for cancer progression. FEBS Lett, 2024, 598: 1301-1327.","journal-title":"FEBS Lett"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev.cellbio.13.1.261","volume":"13","author":"Morgan DO","year":"1997","unstructured":"Morgan DO. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol, 1997, 13: 261-291.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"22622","DOI":"10.1021\/jacs.2c09255","volume":"144","author":"Xiong Y","year":"2022","unstructured":"Xiong Y, Zhong Y, Yim H, Yang X, Park KS, Xie L, Poulikakos PI. Bridged proteolysis targeting chimera (PROTAC) enables degradation of undruggable targets. J Am Chem Soc, 2022, 144: 22622-22632.","journal-title":"J Am Chem Soc"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s11684-023-1027-5","volume":"17","author":"Wang L","year":"2023","unstructured":"Wang L, Yang Z, Li G, Liu Y, Ai C, Rao Y. Discovery of small molecule degraders for modulating cell cycle. Front Med, 2023, 17: 823-854.","journal-title":"Front Med"},{"key":"CITATION40","unstructured":"Zhang M, Zhang L, Hei R, Li X, Cai H, Wu X et al. CDK inhibitors in cancer therapy, an overview of recent development.  Am J Cancer Res  2021, 11: 1913\u20131935."},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pharmthera.2018.06.008","volume":"191","author":"Lynce F","year":"2018","unstructured":"Lynce F, Shajahan-Haq AN, Swain SM. CDK4\/6 inhibitors in breast cancer therapy: current practice and future opportunities. Pharmacol Ther, 2018, 191: 65-73.","journal-title":"Pharmacol Ther"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.2174\/13816128113199990486","volume":"20","author":"Guo D","year":"2014","unstructured":"Guo D, Bell EH, Mischel P, Chakravarti A. Targeting SREBP-1-driven lipid metabolism to treat cancer. Curr Pharm Des, 2014, 20: 2619-2626.","journal-title":"Curr Pharm Des"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/mco2.27","volume":"2","author":"Fu Y","year":"2021","unstructured":"Fu Y, Zou T, Shen X, Nelson PJ, Li J, Wu C, Yang J. Lipid metabolism in cancer progression and therapeutic strategies. MedComm, 2021, 2: 27-59.","journal-title":"MedComm"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"47674","DOI":"10.18632\/oncotarget.10274","volume":"7","author":"Kamarajugadda S","year":"2016","unstructured":"Kamarajugadda S, Becker JR, Hanse EA, Mashek DG, Mashek MT, Hendrickson AM, Mullany LK. Cyclin D1 represses peroxisome proliferator-activated receptor alpha and inhibits fatty acid oxidation. Oncotarget, 2016, 7: 47674-47686.","journal-title":"Oncotarget"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1158\/0008-5472.CAN-15-1646","volume":"76","author":"Lucenay KS","year":"2016","unstructured":"Lucenay KS, Doostan I, Karakas C, Bui T, Ding Z, Mills GB, Hunt KK. Cyclin E associates with the lipogenic enzyme ATP-citrate lyase to enable malignant growth of breast cancer cells. Cancer Res, 2016, 76: 2406-2418.","journal-title":"Cancer Res"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1172\/JCI61462","volume":"122","author":"Zhao X","year":"2012","unstructured":"Zhao X, Feng D, Wang Q, Abdulla A, Xie XJ, Zhou J, Sun Y. Regulation of lipogenesis by cyclin-dependent kinase 8\u2013mediated control of SREBP-1. J Clin Invest, 2012, 122: 2417-2427.","journal-title":"J Clin Invest"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/460A4BA349E94C36A3E2A3EEC9AE28F9","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026172","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/460A4BA349E94C36A3E2A3EEC9AE28F9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:26:14Z","timestamp":1792574774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":46,"URL":"https:\/\/doi.org\/10.3724\/abbs.2026172","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}